Cargando…
Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
Lipasin (also known as C19ORF80, RIFL, ANGPTL8 and betatrophin) is a newly discovered circulating factor that regulates lipid metabolism and promotes pancreatic β-cell proliferation. Whether circulating levels of lipasin in humans are altered in a) type 2 diabetes; b) obesity and c) the postprandial...
Autores principales: | Fu, Zhiyao, Berhane, Feven, Fite, Alemu, Seyoum, Berhane, Abou-Samra, Abdul B., Zhang, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381405/ https://www.ncbi.nlm.nih.gov/pubmed/24852694 http://dx.doi.org/10.1038/srep05013 |
Ejemplares similares
-
A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy
por: Zhang, Ren, et al.
Publicado: (2014) -
A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase
por: Fu, Zhiyao, et al.
Publicado: (2015) -
Plasma Lactate Levels Increase during Hyperinsulinemic Euglycemic Clamp and Oral Glucose Tolerance Test
por: Berhane, Feven, et al.
Publicado: (2015) -
Recombinant betatrophin (Angptl-8/lipasin) ameliorates streptozotocin-induced hyperglycemia and β-cell destruction in neonatal rats
por: Zhang, Di, et al.
Publicado: (2019) -
Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes
por: Espes, Daniel, et al.
Publicado: (2014)